INSM Tingkat bathi reged Insmed Inc

Simbol resmi perusahaan Insmed Inc (INSM)

Gross margin on this GURU.Markets platform chart demonstrates production efficiency, where 83.70 expresses the metric's value today. The success of Insmed Incorporated (INSM) is based on Arikayce sales and brensocatib trials. Revenue is generated by government funds purchasing expensive medications for pulmonology centers. High profitability is ensured by patent protection and a lack of alternative therapy methods for rare lung pathologies.

Insmed Incorporated (INSM): Margin reged saka 04.07.2022 nganti 20.11.2026

Rincian analitis lan laporan data perusahaan Insmed (INSM)

- nilai pasar lan prakiraan target analis:
Analisis dhasar perusahaan:INSM - Insmed Inc.
Produk seri insmed.com

Gross margin serves as a key filter for investment reliability, confirming the issuer's ability to generate profit. This metric is calculated as the share of revenue minus direct production costs, reflecting the business's operational efficiency. An analysis of the operating gross margin allows for an assessment of the pricing power of Insmed Incorporated (INSM). However, dependence on biomaterial imports and geopolitical risks may increase the cost of goods sold, creating pressure on this indicator.